Sample Name	Protocol REF	Date	Performer	Extract Name	Protocol REF	Date	Performer	MS Assay Name	Parameter Value[randomized run order]	Parameter Value[injection mode]	Parameter Value[instrument]	Parameter Value[scan polarity]	Raw Spectral Data File
studygroup_42a87323-fb0c-424b-b09f-c6c88b9425cb_subject#0_sample#0_blood	metabolite extraction	29/08/2019	Dan	studygroup_42a87323-fb0c-424b-b09f-c6c88b9425cb_subject#0_sample#0_blood_extract-20	GC-negative mass spectrometry	29/08/2019	Bob	assay-name-20_blood_GC_neg_run-0	20	GC	Agilent QTOF	negative	acquired-data-20_platform-GC_negative_run-0.mzml.gz
studygroup_42a87323-fb0c-424b-b09f-c6c88b9425cb_subject#0_sample#1_blood	metabolite extraction	29/08/2019	Dan	studygroup_42a87323-fb0c-424b-b09f-c6c88b9425cb_subject#0_sample#1_blood_extract-21	GC-negative mass spectrometry	29/08/2019	Bob	assay-name-21_blood_GC_neg_run-0	21	GC	Agilent QTOF	negative	acquired-data-21_platform-GC_negative_run-0.mzml.gz
studygroup_42a87323-fb0c-424b-b09f-c6c88b9425cb_subject#0_sample#2_blood	metabolite extraction	29/08/2019	Dan	studygroup_42a87323-fb0c-424b-b09f-c6c88b9425cb_subject#0_sample#2_blood_extract-22	GC-negative mass spectrometry	29/08/2019	Bob	assay-name-22_blood_GC_neg_run-0	22	GC	Agilent QTOF	negative	acquired-data-22_platform-GC_negative_run-0.mzml.gz
studygroup_42a87323-fb0c-424b-b09f-c6c88b9425cb_subject#0_sample#3_blood	metabolite extraction	29/08/2019	Dan	studygroup_42a87323-fb0c-424b-b09f-c6c88b9425cb_subject#0_sample#3_blood_extract-23	GC-negative mass spectrometry	29/08/2019	Bob	assay-name-23_blood_GC_neg_run-0	23	GC	Agilent QTOF	negative	acquired-data-23_platform-GC_negative_run-0.mzml.gz
studygroup_42a87323-fb0c-424b-b09f-c6c88b9425cb_subject#1_sample#0_blood	metabolite extraction	29/08/2019	Dan	studygroup_42a87323-fb0c-424b-b09f-c6c88b9425cb_subject#1_sample#0_blood_extract-24	GC-negative mass spectrometry	29/08/2019	Bob	assay-name-24_blood_GC_neg_run-0	24	GC	Agilent QTOF	negative	acquired-data-24_platform-GC_negative_run-0.mzml.gz
studygroup_42a87323-fb0c-424b-b09f-c6c88b9425cb_subject#1_sample#1_blood	metabolite extraction	29/08/2019	Dan	studygroup_42a87323-fb0c-424b-b09f-c6c88b9425cb_subject#1_sample#1_blood_extract-25	GC-negative mass spectrometry	29/08/2019	Bob	assay-name-25_blood_GC_neg_run-0	25	GC	Agilent QTOF	negative	acquired-data-25_platform-GC_negative_run-0.mzml.gz
studygroup_42a87323-fb0c-424b-b09f-c6c88b9425cb_subject#1_sample#2_blood	metabolite extraction	29/08/2019	Dan	studygroup_42a87323-fb0c-424b-b09f-c6c88b9425cb_subject#1_sample#2_blood_extract-26	GC-negative mass spectrometry	29/08/2019	Bob	assay-name-26_blood_GC_neg_run-0	26	GC	Agilent QTOF	negative	acquired-data-26_platform-GC_negative_run-0.mzml.gz
studygroup_42a87323-fb0c-424b-b09f-c6c88b9425cb_subject#1_sample#3_blood	metabolite extraction	29/08/2019	Dan	studygroup_42a87323-fb0c-424b-b09f-c6c88b9425cb_subject#1_sample#3_blood_extract-27	GC-negative mass spectrometry	29/08/2019	Bob	assay-name-27_blood_GC_neg_run-0	27	GC	Agilent QTOF	negative	acquired-data-27_platform-GC_negative_run-0.mzml.gz
studygroup_42a87323-fb0c-424b-b09f-c6c88b9425cb_subject#2_sample#0_blood	metabolite extraction	29/08/2019	Dan	studygroup_42a87323-fb0c-424b-b09f-c6c88b9425cb_subject#2_sample#0_blood_extract-28	GC-negative mass spectrometry	29/08/2019	Bob	assay-name-28_blood_GC_neg_run-0	28	GC	Agilent QTOF	negative	acquired-data-28_platform-GC_negative_run-0.mzml.gz
studygroup_42a87323-fb0c-424b-b09f-c6c88b9425cb_subject#2_sample#1_blood	metabolite extraction	29/08/2019	Dan	studygroup_42a87323-fb0c-424b-b09f-c6c88b9425cb_subject#2_sample#1_blood_extract-29	GC-negative mass spectrometry	29/08/2019	Bob	assay-name-29_blood_GC_neg_run-0	29	GC	Agilent QTOF	negative	acquired-data-29_platform-GC_negative_run-0.mzml.gz
studygroup_42a87323-fb0c-424b-b09f-c6c88b9425cb_subject#2_sample#2_blood	metabolite extraction	29/08/2019	Dan	studygroup_42a87323-fb0c-424b-b09f-c6c88b9425cb_subject#2_sample#2_blood_extract-30	GC-negative mass spectrometry	29/08/2019	Bob	assay-name-30_blood_GC_neg_run-0	30	GC	Agilent QTOF	negative	acquired-data-30_platform-GC_negative_run-0.mzml.gz
studygroup_42a87323-fb0c-424b-b09f-c6c88b9425cb_subject#2_sample#3_blood	metabolite extraction	29/08/2019	Dan	studygroup_42a87323-fb0c-424b-b09f-c6c88b9425cb_subject#2_sample#3_blood_extract-31	GC-negative mass spectrometry	29/08/2019	Bob	assay-name-31_blood_GC_neg_run-0	31	GC	Agilent QTOF	negative	acquired-data-31_platform-GC_negative_run-0.mzml.gz
studygroup_42a87323-fb0c-424b-b09f-c6c88b9425cb_subject#3_sample#0_blood	metabolite extraction	29/08/2019	Dan	studygroup_42a87323-fb0c-424b-b09f-c6c88b9425cb_subject#3_sample#0_blood_extract-32	GC-negative mass spectrometry	29/08/2019	Bob	assay-name-32_blood_GC_neg_run-0	32	GC	Agilent QTOF	negative	acquired-data-32_platform-GC_negative_run-0.mzml.gz
studygroup_42a87323-fb0c-424b-b09f-c6c88b9425cb_subject#3_sample#1_blood	metabolite extraction	29/08/2019	Dan	studygroup_42a87323-fb0c-424b-b09f-c6c88b9425cb_subject#3_sample#1_blood_extract-33	GC-negative mass spectrometry	29/08/2019	Bob	assay-name-33_blood_GC_neg_run-0	33	GC	Agilent QTOF	negative	acquired-data-33_platform-GC_negative_run-0.mzml.gz
studygroup_42a87323-fb0c-424b-b09f-c6c88b9425cb_subject#3_sample#2_blood	metabolite extraction	29/08/2019	Dan	studygroup_42a87323-fb0c-424b-b09f-c6c88b9425cb_subject#3_sample#2_blood_extract-34	GC-negative mass spectrometry	29/08/2019	Bob	assay-name-34_blood_GC_neg_run-0	34	GC	Agilent QTOF	negative	acquired-data-34_platform-GC_negative_run-0.mzml.gz
studygroup_42a87323-fb0c-424b-b09f-c6c88b9425cb_subject#3_sample#3_blood	metabolite extraction	29/08/2019	Dan	studygroup_42a87323-fb0c-424b-b09f-c6c88b9425cb_subject#3_sample#3_blood_extract-35	GC-negative mass spectrometry	29/08/2019	Bob	assay-name-35_blood_GC_neg_run-0	35	GC	Agilent QTOF	negative	acquired-data-35_platform-GC_negative_run-0.mzml.gz
studygroup_42a87323-fb0c-424b-b09f-c6c88b9425cb_subject#4_sample#0_blood	metabolite extraction	29/08/2019	Dan	studygroup_42a87323-fb0c-424b-b09f-c6c88b9425cb_subject#4_sample#0_blood_extract-36	GC-negative mass spectrometry	29/08/2019	Bob	assay-name-36_blood_GC_neg_run-0	36	GC	Agilent QTOF	negative	acquired-data-36_platform-GC_negative_run-0.mzml.gz
studygroup_42a87323-fb0c-424b-b09f-c6c88b9425cb_subject#4_sample#1_blood	metabolite extraction	29/08/2019	Dan	studygroup_42a87323-fb0c-424b-b09f-c6c88b9425cb_subject#4_sample#1_blood_extract-37	GC-negative mass spectrometry	29/08/2019	Bob	assay-name-37_blood_GC_neg_run-0	37	GC	Agilent QTOF	negative	acquired-data-37_platform-GC_negative_run-0.mzml.gz
studygroup_42a87323-fb0c-424b-b09f-c6c88b9425cb_subject#4_sample#2_blood	metabolite extraction	29/08/2019	Dan	studygroup_42a87323-fb0c-424b-b09f-c6c88b9425cb_subject#4_sample#2_blood_extract-38	GC-negative mass spectrometry	29/08/2019	Bob	assay-name-38_blood_GC_neg_run-0	38	GC	Agilent QTOF	negative	acquired-data-38_platform-GC_negative_run-0.mzml.gz
studygroup_42a87323-fb0c-424b-b09f-c6c88b9425cb_subject#4_sample#3_blood	metabolite extraction	29/08/2019	Dan	studygroup_42a87323-fb0c-424b-b09f-c6c88b9425cb_subject#4_sample#3_blood_extract-39	GC-negative mass spectrometry	29/08/2019	Bob	assay-name-39_blood_GC_neg_run-0	39	GC	Agilent QTOF	negative	acquired-data-39_platform-GC_negative_run-0.mzml.gz
studygroup_7adbfe3e-eec8-4697-8284-74cd57ee7f81_subject#0_sample#0_blood	metabolite extraction	29/08/2019	Dan	studygroup_7adbfe3e-eec8-4697-8284-74cd57ee7f81_subject#0_sample#0_blood_extract-0	GC-negative mass spectrometry	29/08/2019	Bob	assay-name-0_blood_GC_neg_run-0	0	GC	Agilent QTOF	negative	acquired-data-0_platform-GC_negative_run-0.mzml.gz
studygroup_7adbfe3e-eec8-4697-8284-74cd57ee7f81_subject#0_sample#1_blood	metabolite extraction	29/08/2019	Dan	studygroup_7adbfe3e-eec8-4697-8284-74cd57ee7f81_subject#0_sample#1_blood_extract-1	GC-negative mass spectrometry	29/08/2019	Bob	assay-name-1_blood_GC_neg_run-0	1	GC	Agilent QTOF	negative	acquired-data-1_platform-GC_negative_run-0.mzml.gz
studygroup_7adbfe3e-eec8-4697-8284-74cd57ee7f81_subject#0_sample#2_blood	metabolite extraction	29/08/2019	Dan	studygroup_7adbfe3e-eec8-4697-8284-74cd57ee7f81_subject#0_sample#2_blood_extract-2	GC-negative mass spectrometry	29/08/2019	Bob	assay-name-2_blood_GC_neg_run-0	2	GC	Agilent QTOF	negative	acquired-data-2_platform-GC_negative_run-0.mzml.gz
studygroup_7adbfe3e-eec8-4697-8284-74cd57ee7f81_subject#0_sample#3_blood	metabolite extraction	29/08/2019	Dan	studygroup_7adbfe3e-eec8-4697-8284-74cd57ee7f81_subject#0_sample#3_blood_extract-3	GC-negative mass spectrometry	29/08/2019	Bob	assay-name-3_blood_GC_neg_run-0	3	GC	Agilent QTOF	negative	acquired-data-3_platform-GC_negative_run-0.mzml.gz
studygroup_7adbfe3e-eec8-4697-8284-74cd57ee7f81_subject#1_sample#0_blood	metabolite extraction	29/08/2019	Dan	studygroup_7adbfe3e-eec8-4697-8284-74cd57ee7f81_subject#1_sample#0_blood_extract-4	GC-negative mass spectrometry	29/08/2019	Bob	assay-name-4_blood_GC_neg_run-0	4	GC	Agilent QTOF	negative	acquired-data-4_platform-GC_negative_run-0.mzml.gz
studygroup_7adbfe3e-eec8-4697-8284-74cd57ee7f81_subject#1_sample#1_blood	metabolite extraction	29/08/2019	Dan	studygroup_7adbfe3e-eec8-4697-8284-74cd57ee7f81_subject#1_sample#1_blood_extract-5	GC-negative mass spectrometry	29/08/2019	Bob	assay-name-5_blood_GC_neg_run-0	5	GC	Agilent QTOF	negative	acquired-data-5_platform-GC_negative_run-0.mzml.gz
studygroup_7adbfe3e-eec8-4697-8284-74cd57ee7f81_subject#1_sample#2_blood	metabolite extraction	29/08/2019	Dan	studygroup_7adbfe3e-eec8-4697-8284-74cd57ee7f81_subject#1_sample#2_blood_extract-6	GC-negative mass spectrometry	29/08/2019	Bob	assay-name-6_blood_GC_neg_run-0	6	GC	Agilent QTOF	negative	acquired-data-6_platform-GC_negative_run-0.mzml.gz
studygroup_7adbfe3e-eec8-4697-8284-74cd57ee7f81_subject#1_sample#3_blood	metabolite extraction	29/08/2019	Dan	studygroup_7adbfe3e-eec8-4697-8284-74cd57ee7f81_subject#1_sample#3_blood_extract-7	GC-negative mass spectrometry	29/08/2019	Bob	assay-name-7_blood_GC_neg_run-0	7	GC	Agilent QTOF	negative	acquired-data-7_platform-GC_negative_run-0.mzml.gz
studygroup_7adbfe3e-eec8-4697-8284-74cd57ee7f81_subject#2_sample#0_blood	metabolite extraction	29/08/2019	Dan	studygroup_7adbfe3e-eec8-4697-8284-74cd57ee7f81_subject#2_sample#0_blood_extract-8	GC-negative mass spectrometry	29/08/2019	Bob	assay-name-8_blood_GC_neg_run-0	8	GC	Agilent QTOF	negative	acquired-data-8_platform-GC_negative_run-0.mzml.gz
studygroup_7adbfe3e-eec8-4697-8284-74cd57ee7f81_subject#2_sample#1_blood	metabolite extraction	29/08/2019	Dan	studygroup_7adbfe3e-eec8-4697-8284-74cd57ee7f81_subject#2_sample#1_blood_extract-9	GC-negative mass spectrometry	29/08/2019	Bob	assay-name-9_blood_GC_neg_run-0	9	GC	Agilent QTOF	negative	acquired-data-9_platform-GC_negative_run-0.mzml.gz
studygroup_7adbfe3e-eec8-4697-8284-74cd57ee7f81_subject#2_sample#2_blood	metabolite extraction	29/08/2019	Dan	studygroup_7adbfe3e-eec8-4697-8284-74cd57ee7f81_subject#2_sample#2_blood_extract-10	GC-negative mass spectrometry	29/08/2019	Bob	assay-name-10_blood_GC_neg_run-0	10	GC	Agilent QTOF	negative	acquired-data-10_platform-GC_negative_run-0.mzml.gz
studygroup_7adbfe3e-eec8-4697-8284-74cd57ee7f81_subject#2_sample#3_blood	metabolite extraction	29/08/2019	Dan	studygroup_7adbfe3e-eec8-4697-8284-74cd57ee7f81_subject#2_sample#3_blood_extract-11	GC-negative mass spectrometry	29/08/2019	Bob	assay-name-11_blood_GC_neg_run-0	11	GC	Agilent QTOF	negative	acquired-data-11_platform-GC_negative_run-0.mzml.gz
studygroup_7adbfe3e-eec8-4697-8284-74cd57ee7f81_subject#3_sample#0_blood	metabolite extraction	29/08/2019	Dan	studygroup_7adbfe3e-eec8-4697-8284-74cd57ee7f81_subject#3_sample#0_blood_extract-12	GC-negative mass spectrometry	29/08/2019	Bob	assay-name-12_blood_GC_neg_run-0	12	GC	Agilent QTOF	negative	acquired-data-12_platform-GC_negative_run-0.mzml.gz
studygroup_7adbfe3e-eec8-4697-8284-74cd57ee7f81_subject#3_sample#1_blood	metabolite extraction	29/08/2019	Dan	studygroup_7adbfe3e-eec8-4697-8284-74cd57ee7f81_subject#3_sample#1_blood_extract-13	GC-negative mass spectrometry	29/08/2019	Bob	assay-name-13_blood_GC_neg_run-0	13	GC	Agilent QTOF	negative	acquired-data-13_platform-GC_negative_run-0.mzml.gz
studygroup_7adbfe3e-eec8-4697-8284-74cd57ee7f81_subject#3_sample#2_blood	metabolite extraction	29/08/2019	Dan	studygroup_7adbfe3e-eec8-4697-8284-74cd57ee7f81_subject#3_sample#2_blood_extract-14	GC-negative mass spectrometry	29/08/2019	Bob	assay-name-14_blood_GC_neg_run-0	14	GC	Agilent QTOF	negative	acquired-data-14_platform-GC_negative_run-0.mzml.gz
studygroup_7adbfe3e-eec8-4697-8284-74cd57ee7f81_subject#3_sample#3_blood	metabolite extraction	29/08/2019	Dan	studygroup_7adbfe3e-eec8-4697-8284-74cd57ee7f81_subject#3_sample#3_blood_extract-15	GC-negative mass spectrometry	29/08/2019	Bob	assay-name-15_blood_GC_neg_run-0	15	GC	Agilent QTOF	negative	acquired-data-15_platform-GC_negative_run-0.mzml.gz
studygroup_7adbfe3e-eec8-4697-8284-74cd57ee7f81_subject#4_sample#0_blood	metabolite extraction	29/08/2019	Dan	studygroup_7adbfe3e-eec8-4697-8284-74cd57ee7f81_subject#4_sample#0_blood_extract-16	GC-negative mass spectrometry	29/08/2019	Bob	assay-name-16_blood_GC_neg_run-0	16	GC	Agilent QTOF	negative	acquired-data-16_platform-GC_negative_run-0.mzml.gz
studygroup_7adbfe3e-eec8-4697-8284-74cd57ee7f81_subject#4_sample#1_blood	metabolite extraction	29/08/2019	Dan	studygroup_7adbfe3e-eec8-4697-8284-74cd57ee7f81_subject#4_sample#1_blood_extract-17	GC-negative mass spectrometry	29/08/2019	Bob	assay-name-17_blood_GC_neg_run-0	17	GC	Agilent QTOF	negative	acquired-data-17_platform-GC_negative_run-0.mzml.gz
studygroup_7adbfe3e-eec8-4697-8284-74cd57ee7f81_subject#4_sample#2_blood	metabolite extraction	29/08/2019	Dan	studygroup_7adbfe3e-eec8-4697-8284-74cd57ee7f81_subject#4_sample#2_blood_extract-18	GC-negative mass spectrometry	29/08/2019	Bob	assay-name-18_blood_GC_neg_run-0	18	GC	Agilent QTOF	negative	acquired-data-18_platform-GC_negative_run-0.mzml.gz
studygroup_7adbfe3e-eec8-4697-8284-74cd57ee7f81_subject#4_sample#3_blood	metabolite extraction	29/08/2019	Dan	studygroup_7adbfe3e-eec8-4697-8284-74cd57ee7f81_subject#4_sample#3_blood_extract-19	GC-negative mass spectrometry	29/08/2019	Bob	assay-name-19_blood_GC_neg_run-0	19	GC	Agilent QTOF	negative	acquired-data-19_platform-GC_negative_run-0.mzml.gz